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Abstract
Higher protein intake, and particularly higher leucine intake, is associated with attenuated loss of lean body mass (LBM) over time in older
individuals. Dietary leucine is thought to be a key mediator of anabolism. This study aimed to assess this relationship over 6 years among younger
and older adult Danes. Dietary leucine intake was assessed at baseline and after 6 years in men and women, aged 35–65 years, participating in the
Danish cohort of the WHO-MONICA (Multinational MONItoring of trends and determinants in CArdiovascular disease) study (n 368). Changes in
LBM over the 6 years were measured by bioelectrical impedance using equations developed for this Danish population. The association between
leucine and LBM changes was examined using multivariate linear regression and ANCOVA analyses adjusted for potential confounders.
After adjustment for baseline LBM, sex, age, energy intake and physical activity, leucine intake was associated with LBM change in those older than
65 years (n 79), with no effect seen in those younger than 65 years. Older participants in the highest quartile of leucine intake (7·1g/d) experienced
LBMmaintenance, whereas lower intakes were associated with LBM loss over 6 years (for trend: β=0·434, P=0·03). Sensitivity analysis indicated no
effect modiﬁcation of sex or the presence of CVD. Greater leucine intake in conjunction with adequate total protein intake was associated with
long-term LBM retention in a healthy older Danish population. This study corroborates ﬁndings from laboratory investigations in relation to protein
and leucine intakes and LBM change. A more diverse and larger sample is needed for conﬁrmation of these results.
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Age-related loss of lean body mass (LBM), particularly skeletal
muscle LBM, and its relationship to mortality is well cited in
epidemiological studies(1,2). Skeletal muscle LBM has been
shown to decline with increasing age, and its reversal made
more difﬁcult, because of development of ‘anabolic resistance’,
which may be related to factors such as dietary protein
inadequacy(3,4), physical inactivity(5), ageing vasculature(6,7)
and chronic low-grade inﬂammation(8).
Previous prospective cohort studies have shown that higher
total protein intake is positively associated with measures of
LBM retention(3,9), whereas additional cross-sectional studies
have reported similar(10) as well as contrasting(11,12) results. The
most recent Nordic Nutritional Recommendations, which
summarise recent key ﬁndings(13,14), indicate that the optimal
daily protein requirements are suggested as 1·1–1·3 g/kg body
weight (BW) in elderly populations (i.e. older than 65 years)(15).
A number of smaller well-designed controlled experiments
have further elucidated that increasing amounts of complete
protein sources containing 2 g or more leucine effectively
stimulate muscle protein synthesis (MPS) in elderly men(16),
with larger doses being related to a greater response(17,18).
Investigations have shown that leucine alone can signal MPS,
and leucine peak, in part, can direct the amplitude of the
resulting anabolic response from protein ingestion. However, in
the long-term, leucine alone has been shown to have no effect
on actual muscle hypertrophy over time(17,19).
Longer-term smaller intervention studies among patients and
healthy elderly (>6 months) that have added a combination of
leucine and the other branched-chain amino acids to normal
intake have shown mixed results, with some reporting an
increase in LBM(20,21), whereas another found no signiﬁcant
change in LBM compared with control(22). Therefore, accretion of
skeletal LBM is most likely to be reliant upon the provision of
adequate leucine in combination with a complete protein source.
Abbreviations: BF, body fat; BW, body weight; LBM, lean body mass; MONICA, Multinational MONItoring of trends and determinants in CArdiovascular
disease; MPS, muscle protein synthesis.
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It has been well established that physical activity in
conjunction with the ingestion of a complete and adequate
protein source yields a greater hypertrophic effect than
either alone(16,18).
Therefore, a recent position study has indicated that foods
containing 2·3–2·8g of leucine should be recommended at each
meal for those over 65 years of age. In addition, a recommenda-
tion that adequate protein intake should be combined with regular
aerobic and resistance training is also suggested(14).
Although there are cross-sectional(10,23) and prospective
data(3) describing associations between total protein intake,
LBM and LBM change, none of these studies have reported the
effect on LBM in relation to dietary intake of leucine. Therefore,
the purposes of this study were to investigate the relationship
between dietary intake of leucine and its relationship with LBM
and LBM change over 6 years and how this may differ for those
younger or older than 65 years of age.
Methods
Subjects
The present study was part of the Danish MONICA (Multinational
MONItoring of trends and determinants in CArdiovascular
disease) project, an international study conducted under the
auspices of the WHO, to monitor CVD trends and determinants.
In 1982, a sample of 4807 subjects was randomly selected from
the Central Person Register of all citizens born in 1922, 1932, 1942
and 1952 and living in eleven municipalities in the Copenhagen
County(24). Of these, 226 were of non-Danish origin and were
excluded. Among the 4581 invited, 3608 participated in a
subsequent health examination in 1982(25). Those who
participated in the baseline study (MONICA1) were invited to a
follow-up examination in 1987–1988 (GEN-MONICA), of which
2987 (83%) attended. After 11 years, 4130 of the 1982 sample
were still alive and lived in Denmark. These participants were
invited to the second follow-up (MONICA10) examination from
1993 to 1994, where 2554 (65%) attended. The non-respondents
have been described in detail elsewhere(26).
Among survivors of the participants of MONICA1, one in
six individuals was invited for a diet history interview at
GEN-MONICA and MONICA10 surveys conducted 6 and 11
years later (n 552). Body composition measures were collected
only at the GEN-MONICA and MONICA10 surveys, and total
information on both dietary and body composition data for
both GEN-MONICA and MONICA10 was available for 368
participants. Of those, leucine intake at MONICA1 was also
available for 233 participants. For the purposes of this study,
data from only GEN-MONICA and MONICA10 will be
used. These two surveys will be referred to as ‘baseline’ and
‘follow-up’, respectively.
The present study was conducted according to the guidelines
laid down in the Declaration of Helsinki (1989) of the World
Medical Association, and the Ethics Committee of the Medicine
Faculty of the Copenhagen County approved all the procedures
involving human subjects. All subjects were informed of
the aims and procedures of the study, and they gave their
written consent.
Anthropometry
BW was measured to the nearest 0·1 kg using a lever balance,
with subjects dressed in light clothing or underwear. Height was
measured without shoes to the nearest 0·5 cm. A bioelectrical
impedance (BIA)-103 body-composition analyzer (RJL Systems)
was used to measure electrical impedance, following the
manufacturer’s instructions. Measurements were taken with a
tetra polar electrode arrangement while the subjects were lying
relaxed on a couch. The electrodes were placed on the dorsal
surfaces of the right hand and foot at the distal metacarpals and
metatarsals, respectively, and between the distal prominence of
the radius and the ulna at the wrist and the medial and lateral
malleoli at the ankle. A speciﬁc equation for estimating body fat
(BF) from impedance, with measurements of total body water
and K as a reference, has been developed speciﬁcally for this
population and reported previously(16):
BF kgð Þ= 0819BW kgð Þ 0279Ht2 =R
cm2 =Ω
  0064 sex ´ BW kgð Þ
+ 0077 age yearsð Þ 0231Ht cmð Þ
+ 14941:
where BF is the body fat, Ht the height and BW the body
weight. Sex was coded as 1 for men and 0 for women. LBM (kg)
was calculated by subtracting BF (kg) from total BW (kg).
LBM and BF measures were available at baseline and
follow-up surveys, but unavailable at MONICA1. Thus, our
analysis focused on change in LBM between these two latter
time points.
Dietary assessment
At baseline and follow-up, the same dietitian interviewed
participants to assess dietary intake based on information from
the previous month, and average daily nutrient and energy
intakes were calculated from this information. Meal patterns,
dishes and foods were explored by interview using a detailed
pre-coded interview form. Quantities were explored using food
models, photo series, cups and measures. This instrument has
been validated in another study(27). Nutrient calculations have
been carried out with the DANKOST programme, which is
derived from the Danish food composition tables. This database
included 835 food items at baseline in 1988, and it was exten-
ded and comprised 1250 food items in 1995. In 1987–1988,
participants gave information on diet intake based on 498
different foods, and at follow-up in 1993–1994 1177 were
recorded. Food contents of leucine and all the other amino
acids were supplied from the food database, which can be
found at www.foodcomp.dk.
Physical activity
Leisure-time activity was based on participants marking one out
of four alternatives: (i) almost completely inactive, reading,
television viewing, cinema-going; (ii) some physical activity
(at least 4 h/week); (iii) regular activity; and (iv) regular, hard
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physical training for competition. These variables were
then reduced by restricting sedentary activity to (i) only and
combining (ii) + (iii) + (iv) as the physically active group.
Demographical variables
Participants recorded present and previous smoking habits
and were classiﬁed as either current smokers or non-current
smokers. Women recorded whether they had entered meno-
pause. Information on previous or prevalent disease, including
CVD and cancer diagnoses, was obtained by following-up each
individual via the unique personal number in the centralised
hospital discharge registry, which is complete with information
for all individuals hospitalised in Denmark since 1973.
Statistical analysis
Differences in demographical data between older (>65 years of
age) and younger (<65 years of age) participants at baseline
were assessed using Mann–Whitney U and χ2 tests for
continuous and categorical variables, respectively.
Multivariable linear regressions and ANCOVA were used
to assess the relationship between leucine at baseline in
1987–1988 and LBM change until 1993–1994, when leucine was
expressed as a continuous variable and categorical (quartiles)
variable, respectively. The covariates included in the primary
model were LBM (kg), BW (kg) and physical activity at base-
line, sex and age. Physical activity was reduced to a binary
variable by dividing the groups as (i) and (ii) + (iii) + (iv).
Interaction product and terms were used in the linear regression
for sensitivity analyses. Sex, physical activity, and presence of
CVD were assessed for their interaction on the relationship
between leucine and LBM. For interactions that approached
signiﬁcance (P< 0·1), stratiﬁed analyses were carried out to
determine their inﬂuence on the overall model.
Results
For the 368 subjects who had diet information and complete
data on changes in body composition between assessments at
baseline in 1987–1988 and follow-up in 1993–1994, the mean
age was 50·4 (SD 10·8) years, 51·1% were female and all were
Caucasian (Table 1). The mean daily leucine intake was
signiﬁcantly greater for those aged 35–55 years compared with
those aged >65 years. In addition, those aged >65 years had
signiﬁcantly lower LBM, total energy and protein intakes, higher
BF percentage and BMI, and were less likely to have never
smoked. For the whole population, there was a mean LBM loss,
which was signiﬁcantly greater for those aged >65 years
compared with those aged <65 years.
Dietary leucine intake and subsequent lean body mass
change over 6 years
After adjustment for sex, age, total energy intake, physical
activity and LBM at baseline, no signiﬁcant associations were
found between baseline leucine intake and the subsequent
6-year LBM change for all individuals (β= 0·000, P= 0·99). For
Table 1. Baseline demographics
(Numbers and percentages; mean values and standard deviations; mean values with their standard errors)
Overall (n 368) Age <65 years (n 289) Age >65 years (n 79)
Mean SD Mean SD Mean SD P*
Female NS†
n 188 148 40
% 51·1 51·2 50·6
Age (years) 50·4 10·8 46·1 8·0 65·7 0·04 0·000
Body weight (kg) 69·6 0·88 68·7 1·01 70·0 0·75 0·6
BMI (kg/m2) 24·2 0·23 24 0·27 25·2 0·46 0·001
LBM (kg) 0·007
Mean 49·2 51·8 48·6
SE 0·66 0·5 1·31
BF% 27·1 0·5 26·5 0·57 31·6 0·91 0·000
Change in LBM (5 year) (kg) − 0·075 1·7 0·04 1·7 − 0·67 0·09 0·008
Total daily energy intake (MJ/d) 8·8 2·9 9·0 3·0 8·7 0·39 0·02
Total daily protein intake (g/d) 74·6 1·5 77·8 1·22 68·9 2·5 0·008
Total daily Leu intake (g/d) 5·47 0·12 5·7 0·14 5·3 0·081 0·004
n % n % n %
Lifetime prevalence of disease
CVD diagnosis (at baseline) 30 8·2 21 7·3 9 11·4 0·03†
Anytime (until 1994) 41 11·1 27 9·3 14 17·7 0·04†
Physical activity leisure
Sedentary 84 22·8 70 24·2 14 17·7 NS†
Physically active 284 77·2 219 75·8 65 82·3 NS†
LBM, lean body mass; BF%, body fat percentage.
* P value comparing those over 65 years of age with those younger than 65 years.
† χ2 Test, all others Mann–Whitney U tests with the grouping >65 or <65 years of age; sedentary: almost completely inactive: reading, television viewing, cinema-going; physically
active: some physical activity (at least 4 h/week) or more.
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those aged >65 years at baseline, a linear relationship was
found for leucine intake as a continuous variable (β= 0·434,
P= 0·028). Fig. 1 shows results of the adjusted ANCOVA
for LBM changes by quartiles of leucine intake, which
indicated that only those in highest quartile of leucine intake
(7·1 (SD 0·6) g/d) maintained LBM (adjusted mean change in
LBM: 0·24 kg; 95% CI −0·67, 1·14). The lower three
quartiles experienced loss of LBM over time (Q1: −1·24 kg;
95% CI −1·9, −0·5; Q2: −0·99 kg; 95% CI −0·88, 0·5; Q3: −0·2 kg;
95% CI −0·88, 0·5). For those aged <65 years at baseline,
no association was found between leucine intake as a
continuous variable and change in LBM (β=− 0·082, P= 0·39).
In addition, no differences were seen between any of the
quartile groups (Q1: 0·01 kg; 95% CI −0·5, 0·5; Q2: −0·06 kg;
95% CI −0·5, 0·4; Q3: 0·4 kg; 95% CI 0·0, 0·8; Q4: −0·1 kg; 95 %
CI −0·3, +0·1. Table 2 shows total protein and leucine
intakes across the four quartiles of intake and the corresponding
change in LBM for younger and older individuals. Compared
with those older than 65 years, relative total protein and
leucine intakes were higher in all four corresponding quartiles
for those younger than 65 years.
Sensitivity analyses were performed that included interactions
with history of CVD diagnosis at baseline and/or follow-up, sex
or physical activity. For those older than 65 years, a signiﬁcant
interaction was found for ‘any diagnosis of CVD’ (i.e. diagnosed
with CVD at baseline or follow-up)× leucine (β: −1·031,
P= 0·008), whereas no interaction was seen for younger indivi-
duals (β: 0·199, P= 0·25). After restricting the analysis to only
older individuals free of CVD, a signiﬁcant association for leucine
and change in LBM (β= 0·481, P= 0·04; n 65) was seen.
However, for those over 65 years and with ‘any diagnosis of
CVD’, no relationship was found between leucine and LBM
change (β=− 0·171, P= 0·76; n 14). Post hoc analyses revealed
that those free of CVD (n 65) lost less LBM than those with any
diagnosis of CVD (n 14) over 6 years (mean change: −0·35
(SD 1·4) v. −1·3 (SD 1·8) kg, respectively; t= 2·2, P= 0·03).
For those younger than 65 years, a signiﬁcant interaction was
found by level of physical activity (P= 0·03). However, when
analyses were restricted to those who were sedentary (P= 0·28;
n 69) or physically active (P= 0·065; n 217), no signiﬁcant
associations were found between leucine and LBM change. No
statistically signiﬁcant interaction for leucine×physical activity
was seen in older individuals. A trend for sex× leucine
interaction was noted in older individuals (β: 0·72, P= 0·11).
However, no signiﬁcant trends were noted when analyses were
restricted to males (β: 0·445, P= 0·10) or females only (β: 0·385,
P= 0·14).
Discussion
In a healthy population subset of adult Danes, higher dietary
protein and leucine intakes were associated with greater LBM
retention in those aged 65 years, whereas no association was
found for those younger than 65 years. For those aged >65
years, LBM was maintained over 6 years in individuals who
consumed a mean of 7·1 g of leucine/d, with a corresponding
mean total protein intake of 1·25 g/kg BW per d. Therefore, a
long-term relationship between leucine intake in the presence
of adequate total protein consumption and LBM retention was
shown. This association remained signiﬁcant after adjustment
for initial LBM, total energy intake, age, sex, physical activity,
smoking status and presence of CVD.
The presence of a diagnosis of CVD at any time during the
6-year follow-up period was associated with greater LBM loss,
1st 2nd 3rd 4th


























Fig. 1. Six-year lean body mass (LBM) change for quartiles of leucine intake.
*P=<0·05. Relates to quartile values for those >65 years of age (for
trend as a continuous variable: β= 0·43, P= 0·028); relates to those <65
years of age (for trend: β=− 0·08, P= 0·393). Adjusted model for ANCOVA
includes LBM at baseline, total energy intake, age, sex and physical activity.
Table 2. Quartiles of total leucine and corresponding relative total protein intakes for those younger and older than 65 years of age
(Mean values and standard deviations)
Quartile 1 Quartile 2 Quartile 3 Quartile 4
Mean SD Mean SD Mean SD Mean SD
Protein intake (g/kg BW per d)
<65 years 0·75 0·2 0·94 0·2 1·10 0·2 1·40 0·4
>65 years* 0·61 0·2 0·92 0·1 0·97 0·2 1·26 0·2
Leu intake (g/d)
<65 years 3·67 0·6 4·80 0·25 5·88 0·35 8·08 1·5
>65 years* 3·03 0·9 4·44 0·3 5·56 0·4 7·12 0·6
BW, body weight.
* Compared with those <65 years, those aged >65 years had significantly lower intakes of protein and leucine for all quartiles (P<0·05).
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and similarly in CVD-free individuals, leucine and total protein
intakes had a more marked inﬂuence over LBM. Individuals
with a diagnosis of CVD may have been exposed to greater
levels of inﬂammation that may have increased anabolic resis-
tance in them(8), which in turn may have dampened the effect
of anabolic stimuli including the muscle protein synthetic effects
of protein intake. Alternatively, as previous case–control studies
in Nordic countries have indicated that those with CVD repor-
ted higher-quality diets than healthy controls at the time after
diagnosis(28), it is plausible to suggest that those diagnosed with
CVD may have altered their dietary intake rendering their
baseline data on diet intake unreliable, which may explain why
the relationship between leucine and LBM change was
strengthened when including only those without CVD.
Previous observational research ﬁndings from the Health,
Ageing and Body Composition (Health ABC) study have indicated
that individuals in the lowest quintile of protein intake (0·7g/kg
BW) experienced a 40% greater loss of LBM over 3 years
compared with the highest quintile (1–1·2g/kg BW)(3). Similar
observations were made in a Chinese sample assessing LBM
change by mid-arm circumference(9). In addition, protein intakes
from animal meats, which typically contain the highest
concentrations of leucine(29), have been associated with greater
LBM retention compared with vegetable-based protein(3,23).
Laboratory data in younger and older individuals have indicated
that after a meal containing 2g of leucine in the form of a
complete whey protein isolate(16), or after 170g of meat(30), MPS is
increased, resulting in net LBM gain. More in-depth investigations
have shown that for those over 65 years, a positive dose–response
relationship between protein ingestion and MPS exists for up to
40 g of protein (containing 4g of leucine). However, younger
individuals experienced no further gains after 20 g of leucine
(containing 2g leucine) at one meal(31). To frame these ﬁndings
correctly, it is important to note that free leucine added to an
adequate and complete protein source does not provide further
anabolic advantages(32). Thus, leucine is an essential factor and a
useful surrogate marker for determining effect on MPS, yet total
essential amino acid intake will ultimately determine the anabolic
effect of protein ingestion.
Combining both bodies of literature, a recently published
position stand concluded that protein sources containing
2·3–2·8g of leucine are recommended at each main meal
(total intake of 6·6–8·4g/d) to optimise LBM outcomes in older
populations (>65 years)(14). Our study is the ﬁrst to conﬁrm both
observational and experimental data with regard to LBM and
leucine intake. Furthermore, our results conﬁrmed that protein
consumed through foods without protein supplementation seems
sufﬁcient to maintain LBM for a longer term in older populations.
In the present study, there was no association between protein
intake and LBM change for those younger than 65 years. From
laboratory data, it is known that older individuals need more
protein than younger individuals in order to elicit equivalent
responses in MPS(16). Therefore, declines in anabolic
response(33,34) in older individuals may partly explain why higher
protein intake may be required for clinically relevant LBM pre-
servation, than for those younger than 65 years. Similarly, markers
of chronic inﬂammation are known to contribute to age-related
sarcopenia(8) and are predictive of CVD(35). No statistically
signiﬁcant interactions were seen overall for sex× leucine;
however, a trend for interaction was noted for older but not
younger individuals. Previous literature suggests that women may
have a higher rate of basal MPS(36,37); however, one study
indicated a similar MPS response to feeding in older men and
women (65–80 years)(37). Our ﬁndings agree with one previous
study that reported no differences between sexes in middle-aged
men and women in either basal or fed states(38). However, a
greater sample size with more detailed physical activity data may
elucidate sex differences in future studies. No interaction was
noted for physical activity× leucine. The current literature
indicates that resistance training and leucine intake combined
produce greater MPS responses and LBM gains compared with
either intervention alone(18). In addition, a cross-sectional study
reported greater skeletal muscle LBM for those having higher
protein intakes in conjunction with both vigorous aerobic training
or strength training(10). Our physical activity classiﬁcation of
‘sedentary’ or ‘non-sedentary’ did not delineate aerobic and
resistance exercise, thus potentially explaining the lack of effect
seen in the previous literature.
A few limitations should be noted. It is possible that assessment
of dietary intake of leucine at baseline may have been inadequate
to capture important dietary exposures over the subsequent
6 years; however, the power was adequate to detect a linear
relationship. Furthermore, we showed previously that fat- and/or
carbohydrate-rich foods are most under-reported, and protein
intake is also under-reported in general and particularly among the
more obese(39). Therefore, both random reporting error, which
would tend to attenuate, and non-random reporting error, which
may have inﬂated the observed association, are possible in the
present study(39). The net effect of such opposite acting errors is
unknown. However, LBM retention in older individuals occurred
at similar amounts protein and leucine previously reported to elicit
net LBM growth in both laboratory and epidemiological studies(14).
In addition, the reliability of our results related to measurement of
LBM was strengthened by using a population-speciﬁc algorithm
generated from the measurement of total body water and
total K as reference(40). Our entire sample included Danes of
Caucasian descent; thus, our results are most likely valid for
Caucasian populations and will require conﬁrmation in other
races. In contrast, the use of BIA as the method of body
composition assessment is likely to be less accurate than a
more current gold standard measure using dual-energy X-ray
absorptiometry or computer tomography scan(41). However, the
use of a population-speciﬁc BIA algorithm used for this trial
speciﬁcally is a factor that may have improved the precision of
these measures. Finally, resistance training has been the most
common type of exercise stimulus for measurement of anabolic
response, and data for resistance training were not available.
Conclusion
For Danes aged 65 years, greater dietary intake of leucine is
associated with greater retention of LBM over 6 years. These results
conﬁrm previous observational and laboratory ﬁndings that to
avoid loss of LBM in older populations a mean intake of 1·25g
of protein/kg BW per d containing 7·1g/d of leucine
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(approximately 2·3–2·4g/main meal) may be required. These
ﬁndings should be conﬁrmed in a larger and more diverse
population.
Acknowledgements
The authors thank the participants in the Danish cohort of the
WHO MONICA trial.
Funding for travel to perform the research was provided by the
University of Queensland (UQ) through the Graduate Student
International Travel Award (GSITA). Research and statistical
analysis support was provided by the Institute of Preventive
Medicine, Bispebjerg and Frederiksberg Hospitals. This research
was supported by the UQ GSITA and by a Danish MRC grant
from the FREJA programme (Female Researchers in Joint Action).
The authors’ responsibilities were as follows – C. K. M.:
analysis, drafting of the manuscript; M. Z. A., S. C., J. B. and B. L. H.:
critical revision of the manuscript; K. R.: data extraction,
translation and design of data analysis; C. K. M. and B. L. H.:
study design; B. L. H.: collection of data; C. K. M., M. Z. A. and
B. L. H.: interpretation of data. All authors read and approved
the ﬁnal manuscript.
The authors declare that there are no conﬂicts of interest.
References
1. Bunout D, de la Maza MP, Barrera G, et al. (2011) Association
between sarcopenia and mortality in healthy older people.
Australas J Ageing 30, 89–92.
2. Muscaritoli M, Anker SD, Argilés J, et al. (2010)) Consensus
deﬁnition of sarcopenia, cachexia and pre-cachexia: joint
document elaborated by Special Interest Groups (SIG)
‘cachexia-anorexia in chronic wasting diseases’ and ‘nutrition
in geriatrics’. Clin Nutr 29, 154–159.
3. Houston DK, Nicklas BJ & Ding J (2008) Dietary protein intake
is associated with lean mass change in older, community-
dwelling adults: the Health, Aging, and Body Composition
(Health ABC) Study. Am J Clin Nutr 87, 150–155.
4. Beasely JM, LaCroix AZ, Neuhouser ML, et al. (2010) Protein
intake and incident frailty in the Women’s Health Initiative
Observational Study. J Am Geriatr Soc 58, 1063–1071.
5. Hughes VA, Roubenoff R, Wood M, et al. (2004) Anthropo-
metric assessment of 10-y changes in body composition in the
elderly. Am J Clin Nutr 80, 475–482.
6. Dillon EL, Casperson SL, DurhamWJ, et al. (2011) Muscle protein
metabolism responds similarly to exogenous amino acids in
healthy younger and older adults during NO-induced hyperemia.
Am J Physiol Regul Integr Comp Physiol 301, R1408–R1417.
7. Timmerman KL, Lee JL, Fujita S, et al. (2010) Pharmacological
vasodilation improves insulin-stimulated muscle protein
anabolism but not glucose utilization in older adults. Diabetes
59, 2764–2771.
8. Beyer I, Mets T & Bautmans I (2012) Chronic low-grade
inﬂammation and age-related sarcopenia. Curr Opin Clin
Nutr Metab Care 15, 12–22.
9. Stookey JD, Adair LS & Popkin BM (2005) Do protein and
energy intakes explain long-term changes in body composi-
tion? J Nutr Health Ageing 9, 5–17.
10. Morris MS & Jacques PF (2012) Total protein, animal protein
and physical activity in relation to muscle mass in middle-aged
and older Americans. Br J Nutr 109, 1294–1303.
11. Mitchell D, Haan MN, Steinberg FM, et al. (2003) Body
composition in the elderly: the inﬂuence of nutritional factors
and physical activity. J Nutr Health Ageing 7, 130–139.
12. Baumgartner RN, Waters DL, Gallagher D, et al. (1999)
Predictors of skeletal muscle mass in elderly men and women.
Mech Ageing Dev 107, 123–136.
13. Volpi E, Campbell WW, Dwyer JT, et al. (2012) Is the optimal
level of protein intake for older adults greater than the
recommended dietary allowance? J Gerontol A Biol Sci Med
Sci 68, 677–681.
14. Bauer J, Biolo G, Cederholm T, et al. (2013) Evidence-based
recommendations for optimal dietary protein intake in older
people: a position paper from the PROT-AGE Study Group.
J Am Med Dir Assoc 14, 542–559.
15. Nordic Council of Ministers (2014) Nordic Nutrition Recom-
mendations 2012. Copenhagen: Nordic Council of Ministers.
16. Yang Y, Breen L, Burd NA, et al. (2012) Resistance exercise
enhances myoﬁbrillar protein synthesis with graded intakes of
whey protein in older men. Br J Nutr 108, 1–9.
17. Breen L & Phillips SM (2011) Skeletal muscle protein
metabolism in the elderly: interventions to counteract the
‘anabolic resistance’ of ageing. Nutr Metab 8, 68–68.
18. Churchward-Venne TA, Burd NA & Phillips SM (2012) Nutri-
tional regulation of muscle protein synthesis with resistance
exercise: strategies to enhance anabolism. Nutr Metab 9, 40.
19. Norton LE, Layman DK, Bunpo P, et al. (2009) The leucine
content of a complete meal directs peak activation but not
duration of skeletal muscle protein synthesis and mammalian
target of rapamycin signaling in rats. J Nutr 139, 1103–1109.
20. Aquilani R, Opasich C, Gualco A, et al. (2008) Adequate
energy-protein intake is not enough to improve nutritional
and metabolic status in muscle-depleted patients with chronic
heart failure. Eur J Heart Fail 10, 1127–1135.
21. Fuller JC, Baier S, Flakoll P, et al. (2011) Vitamin D status affects
strength gains in older adults supplemented with a combination
of β-hydroxy-β-methylbutyrate, arginine, and lysine. J Parenter
Enteral Nutr 35, 757–762.
22. Verhoeven S, Vanschoonbeek K, Verdijk LB, et al. (2009)
Long-term leucine supplementation does not increase muscle
mass or strength in healthy elderly men. Am J Clin Nutr 89,
1468–1475.
23. Aubertin-Leheudre M & Adlercreutz H (2009) Relationship
between animal protein intake and muscle mass index in
healthy women. Br J Nutr 102, 1803–1810.
24. Hartz AJ, Rupley DC & Rimm AA (1984) The association of
girth measurements with disease in 32,856 women. Am J
Epidemiol 119, 71–80.
25. Jensen KH & Jorgensen T (1991) Incidence of gallstones in a
Danish population. Gastroenterology 100, 790–794.
26. Heitmann BL (1991) Body fat in the adult Danish population aged
35–65 years: an epidemiological study. Int J Obes 15, 535–545.
27. Heitmann BL (1993) The inﬂuence of fatness, weight change,
slimming history and other lifestyle variables on diet reporting
in Danish men and women aged 35–65 years. Int J Obes 17,
329–336.
28. Ma Y, Olendzki BC, Pagoto SL, et al. (2010) What are patients
actually eating: the dietary practices of cardiovascular disease
patients. Curr Opin Cardiol 25, 518–521.
29. United States Department of Agriculture (2009) USDA
National Nutrient Databank for food composition. http://
www.ars.usda.gov/research/projects/projects.htm?accn_no=
416473 (accessed 10 December 2013).
30. Robinson MJ, Burd NA, Breen L, et al. (2013) Dose-dependent
responses of myoﬁbrillar protein synthesis with beef ingestion
are enhanced with resistance exercise in middle-aged men.
App Physiol Nutr Metab 38, 120–125.
Prevention of lean body mass loss by leucine 1561
https://www.cambridge.org/core/terms. https://doi.org/10.1017/S0007114516000611
Downloaded from https://www.cambridge.org/core. Syddansk Universitesbibliotek, on 18 Aug 2017 at 10:46:07, subject to the Cambridge Core terms of use, available at
31. Breen L & Phillips SM (2013) Interactions between exercise
and nutrition to prevent muscle waste during ageing. Br J Clin
Pharmacol 75, 708–715.
32. Koopman R, Verdijk LB, Beelen M, et al. (2008) Co-ingestion
of leucine with protein does not further augment post-exercise
muscle protein synthesis rates in elderly men. Br J Nutr 99,
571–580.
33. Taaffe DR (2006) Sarcopenia: exercise as a treatment strategy.
Aust Fam Physician 35, 130–134.
34. Haran P, Rivas D & Fielding R (2012) Role and potential
mechanisms of anabolic resistance in sarcopenia. J Cachexia
Sarcopenia Muscle 3, 157–162.
35. Danesh J, Whincup P, Walker M, et al. (2000) Low grade
inﬂammation and coronary heart disease: prospective study
and updated meta-analyses. BMJ 321, 199–204.
36. Henderson GC, Nair KS, Dhatariya K, et al. (2009) Higher
muscle protein synthesis in women than men across the
lifespan, and failure of androgen administration to amend
age-related decrements. FASEB J 23, 631–641.
37. Smith GI, Atherton P, Villareal DT, et al. (2008) Differences in
muscle protein synthesis and anabolic signaling in the post-
absorptive state and in response to food in 65-80 year old men
and women. PLoS ONE 3, e1875.
38. Smith GI, Atherton P, Reeds DN, et al. (2009) No major
sex differences in muscle protein synthesis rates in the
postabsorptive state and during hyperinsulinemia-
hyperaminoacidemia in middle-aged adults. J Appl Physiol
107, 1308–1315.
39. Heitmann BL & Frederiksen P (2007) Imprecise methods may
both obscure and aggravate a relation between fat and
breast cancer. Eur J Clin Nutr 61, 925–927.
40. Heitmann BL (1990) Prediction of body water and fat in adult
Danes from measurement of electrical impedance. A
validation study. Int J Obes 14, 789–802.
41. Brodie DPHD, Moscrip VMSC & Hutcheon RMSC (1998) Body
composition measurement: a review of hydrodensitometry,
anthropometry, and impedance methods. Nutrition 14,
296–310.
1562 C. K. McDonald et al.
https://www.cambridge.org/core/terms. https://doi.org/10.1017/S0007114516000611
Downloaded from https://www.cambridge.org/core. Syddansk Universitesbibliotek, on 18 Aug 2017 at 10:46:07, subject to the Cambridge Core terms of use, available at
